Silvio E Inzucchi Selected Research

Atherosclerosis

1/2019	Understanding Contemporary Use of Thiazolidinediones.
3/2015	SGLT-2 inhibitors and cardiovascular risk: proposed pathways and review of ongoing outcome trials.
7/2005	Insulin-sensitizing antihyperglycemic drugs and mortality after acute myocardial infarction: insights from the National Heart Care Project.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Silvio E Inzucchi Research Topics

Disease

147	Heart Failure 05/2024 - 07/2003
122	Type 2 Diabetes Mellitus (MODY) 05/2024 - 01/2002
38	Stroke (Strokes) 04/2024 - 06/2003
38	Myocardial Infarction 04/2024 - 06/2005
35	Cardiovascular Diseases (Cardiovascular Disease) 02/2024 - 07/2005
25	Insulin Resistance 01/2022 - 03/2002
22	Hypoglycemia (Reactive Hypoglycemia) 03/2024 - 12/2004
20	Hyperglycemia 08/2016 - 06/2004
17	Cardiomyopathies (Cardiomyopathy) 05/2024 - 10/2019
16	Transient Ischemic Attack 03/2024 - 06/2003
15	Diabetes Mellitus 01/2024 - 06/2004
15	Ischemic Stroke 09/2022 - 06/2003
14	Kidney Diseases (Kidney Disease) 02/2024 - 12/2014
14	Chronic Renal Insufficiency 11/2023 - 12/2014
13	Critical Illness (Critically Ill) 01/2016 - 02/2004
12	Albuminuria 12/2023 - 03/2015
10	Atrial Fibrillation 01/2023 - 01/2018
8	Prediabetic State (Prediabetes) 01/2023 - 01/2003
7	Heart Diseases (Heart Disease) 01/2023 - 01/2021
6	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2023 - 01/2005
6	Infections 01/2023 - 11/2015
6	Weight Loss (Weight Reduction) 11/2022 - 01/2018
6	Bone Fractures (Bone Fracture) 01/2022 - 04/2016
5	Hypertension (High Blood Pressure) 12/2023 - 01/2018
5	Coronary Artery Disease (Coronary Atherosclerosis) 01/2023 - 01/2015
5	Body Weight (Weight, Body) 01/2023 - 07/2010
5	Obesity 11/2022 - 01/2003
4	Chronic Obstructive Pulmonary Disease (COPD) 03/2024 - 01/2021
4	Weight Gain 03/2024 - 04/2016
4	Peripheral Arterial Disease 01/2024 - 01/2018
4	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 10/2022 - 08/2016
4	Neoplasms (Cancer) 01/2021 - 09/2004
4	Overweight 01/2019 - 01/2018
4	Glucose Intolerance 01/2011 - 01/2003
3	Hypovolemia 12/2023 - 08/2016
3	COVID-19 09/2023 - 11/2022
3	Frailty 01/2023 - 01/2022
3	Obstructive Sleep Apnea 01/2023 - 12/2020
3	Gout 01/2023 - 01/2022
3	Edema (Dropsy) 01/2023 - 04/2016
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 01/2011
3	Diabetic Nephropathies (Diabetic Nephropathy) 12/2020 - 01/2018
3	Lactic Acidosis 10/2020 - 12/2014
3	Acute Coronary Syndrome 01/2019 - 11/2008
3	Atherosclerosis 01/2019 - 07/2005
3	Ischemia 04/2009 - 08/2004
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 03/2024 - 01/2023
2	Sudden Death 01/2024 - 01/2021
2	Sleep Apnea Syndromes (Sleep Apnea) 12/2023 - 01/2023
2	Hypotension (Low Blood Pressure) 12/2023 - 01/2020
2	Ketosis 01/2023 - 01/2022

Drug/Important Bio-Agent (IBA)

87	dapagliflozinIBA 05/2024 - 01/2019
87	Glucose (Dextrose)FDA LinkGeneric 05/2024 - 01/2003
64	empagliflozinIBA 02/2024 - 06/2014
40	Insulin (Novolin)FDA Link 03/2024 - 03/2002
27	Sodium-Glucose Transport ProteinsIBA 05/2024 - 11/2015
25	SodiumIBA 04/2024 - 01/2017
25	Sodium-Glucose Transporter 2 InhibitorsIBA 11/2023 - 06/2014
24	Metformin (Glucophage)FDA LinkGeneric 01/2024 - 01/2003
24	Pioglitazone (Actos)FDA Link 09/2022 - 06/2003
19	Blood Glucose (Blood Sugar)IBA 01/2023 - 06/2003
18	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022 - 01/2002
12	Brain Natriuretic Peptide (Natrecor)FDA Link 05/2024 - 10/2019
12	DiureticsIBA 11/2023 - 08/2016
10	CreatinineIBA 03/2024 - 07/2016
9	omega-Chloroacetophenone (Mace)IBA 04/2024 - 01/2018
9	Natriuretic PeptidesIBA 01/2023 - 10/2019
7	pro-brain natriuretic peptide (1-76)IBA 03/2024 - 10/2019
6	Hemoglobins (Hemoglobin)IBA 02/2024 - 12/2010
6	Uric Acid (Urate)IBA 12/2023 - 03/2015
6	AlbuminsIBA 01/2023 - 01/2017
6	ThiazolidinedionesIBA 01/2019 - 03/2002
5	SymportersIBA 04/2024 - 01/2019
5	Liraglutide FDA Link 01/2024 - 09/2017
5	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2021 - 05/2012
4	CanagliflozinIBA 01/2023 - 01/2018
4	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2019 - 01/2015
4	2,4-thiazolidinedione (thiazolidinedione)IBA 01/2019 - 07/2003
4	lorcaserinIBA 01/2019 - 01/2018
4	5-HT2C Serotonin ReceptorIBA 01/2019 - 01/2018
4	Adenosine (Adenocard)FDA LinkGeneric 09/2013 - 08/2004
3	Angiotensin Receptors (Angiotensin II Receptor)IBA 03/2024 - 10/2020
3	Neprilysin (Neutral Endopeptidase)IBA 03/2024 - 10/2020
3	Sitagliptin Phosphate (Januvia)FDA Link 01/2024 - 07/2014
3	glimepiride (Amarel)FDA LinkGeneric 01/2024 - 01/2023
3	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 02/2023 - 07/2014
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 10/2019
3	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 01/2023 - 01/2020
3	Triglycerides (Triacylglycerol)IBA 01/2021 - 03/2002
3	Angiotensin Receptor AntagonistsIBA 01/2019 - 08/2017
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2024 - 11/2004
2	Insulin Glargine (Lantus)FDA Link 01/2024 - 01/2023
2	(2S,3R,4R,5S,6R)- 2- (4- chloro- 3- (4- ethoxybenzyl)phenyl)- 6- (methylthio)tetrahydro- 2H- pyran- 3,4,5- triolIBA 11/2023 - 01/2021
2	AnticoagulantsIBA 01/2023 - 11/2022

Therapy/Procedure

85	Therapeutics 05/2024 - 01/2002
23	Glycemic Control 01/2023 - 01/2002
10	Secondary Prevention 04/2024 - 12/2014
4	Surgical Amputation (Amputations) 01/2023 - 01/2018
4	Patient Readmission 10/2022 - 07/2005
3	Renal Replacement Therapy (Therapies, Renal Replacement) 02/2024 - 07/2016